The Delta Plus type of SARS-CoV2 has been found in 86 samples across the country so far, according to the government, and has not resulted in an exponential increase in cases. “We detected the Delta Plus variant in 86 (genome) samples (sequenced),” said Sujit Singh, director of the National Center for Disease Control (NCDC), at a press conference held by the health ministry.
According to him, there are four sorts of Delta Plus variants: AY1 (B.1.617.2.1), AY2, AY3, and one more sub-lineage, in which one more gene has been discovered and its lone sample was discovered in Maharashtra. Maharashtra has the most samples (34), followed by Madhya Pradesh (11) and Tamil Nadu (11), according to him (10).
“The identification of 86 samples from various locations since March, with no increase (in cases) in any district (as a result of it), or limiting it to any single state, implies that this (Delta Plus variation) does not have the capacity to cause any exponential spike.” “Through its transmission, this variety has not resulted to any huge exponential rise,” Singh added.
“Over and above the Delta variety, there is no evidence of deleterious impacts,” V K Paul, Member (Health), Niti Aayog, said. According to Singh, the Delta variation was found in 80-90 percent of the samples sequenced across all INSACOG laboratories.
The Indian Council of Medical Research (ICMR), the Department of Science and Technology (DST), the Council for Scientific and Industrial Research (CSIR), and the Department of Biotechnology are all part of the INSACOG consortium (DBT). According to Paul, the Delta version is “controlling the nation and the world,” and many countries are seeing an increase in COVID-19 cases as a result of it.
The Delta variety was the primary cause of the country’s devastating second coronavirus outbreak, which occurred between March and May. It wreaked havoc on the health-care system, killing thousands and infecting millions. According to a World Health Organization (WHO) assessment, the Delta variant’s transmissibility and attack rate are higher than the other viral variations.
If the transmission rate of the original SARS-CoV2 virus was 100, the transmission rate of the Alpha variant, which originated in the United Kingdom, was 60% higher. Paul explained that Delta’s attack rate is 60% higher than Alpha’s. The Delta variety has a higher viral load, which raises the risk of hospitalisation, according to him. Vaccines, on the other hand, can help avoid serious sickness and death from this variety, according to Paul.
The INSACOG network has sequenced 58,240 samples, according to Singh. He noted that the B.1.617.3 and Kappa variants are being investigated. According to Singh, for each new variant, a rapid reaction strategy is developed and governmental directives are issued. When a novel mutant is discovered in a lab, he says, it should be tracked and traced as soon as possible.
The states have been asked to develop rapid reaction teams at the medical college level, according to Singh. He went on to say that many nations have begun to apply it. A patient will be contacted by the teams. A microbiologist, a public health expert, and a clinician will be on the teams to assess the disease’s severity. The scientists will take more samples and send them to be sequenced, as well as establish the severity of the condition and the potential public health consequences of the novel mutation.
